Material Transfer and Evaluation Agreement Sample Contracts
AMENDMENT NO. 2 TO THE MATERIAL TRANSFER AND EVALUATION AGREEMENT between Ceres, Inc. and The Texas A&M University SystemMaterial Transfer and Evaluation Agreement • January 10th, 2013 • Ceres, Inc. • Agricultural production-crops
This Amendment No. 2 is made and entered into by and between Ceres, Inc. (“CERES”), a corporation with principal offices at Thousand Oaks, California, and The Texas A&M University System (“SYSTEM”) of which Texas A&M AgriLife Research (“AGRILIFE”) is a member, both having principal offices in College Station, Texas, parties to the Material Transfer and Evaluation Agreement dated April 23, 2008 as subsequently amended on April 23, 2011.
Material Transfer and Evaluation Agreement between Ceres, Inc. and The Texas A&M University SystemMaterial Transfer and Evaluation Agreement • August 29th, 2011 • Ceres, Inc. • Agricultural production-crops • Texas
This material transfer and evaluation agreement (“Agreement”) is made and entered into by and between Ceres, Inc. (“CERES”), a corporation with principal offices at Thousand Oaks, California, and The Texas A&M University System (“SYSTEM”), of which Texas AgriLife Research (“TAES”), is a part, having principal offices in College Station, Texas. The parties to this Agreement are collectively referred to as the “Parties” and individually as a “Party.”
MATERIAL TRANSFER AND EVALUATION AGREEMENTMaterial Transfer and Evaluation Agreement • January 17th, 2025 • Odyssey Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Odyssey Therapeutics, Inc., a company organized and existing under the laws of Delaware with offices at 51 Sleeper Street, Boston, MA 02210 (“Company” or “Odyssey”).
MATERIAL TRANSFER AND EVALUATION AGREEMENT THIS MATERIAL TRANSFER AND EVALUATION AGREEMENT (the “MTE Agreement,” andMaterial Transfer and Evaluation Agreement • July 29th, 2025 • ImmunoPrecise Antibodies Ltd. • Pharmaceutical preparations
together with its Appendices, the “MTEA”) is made as of the date of the last signature below (the “Effective Date”) by and between Biotheus, Inc. with an address at 10B, Building 4, No 1 Keji 7th Road, Xiang Zhou District, Tangjiawan Town, Zhuhai City, Guangdong Province, China (“Biotheus”), acting in its own name and on behalf of its Affiliates (listed in Appendix 2), and Talem Therapeutics LLC, a US company being a subsidiary of ImmunoPrecise Antibodies with an address at 4837 Amber Valley Parkway, Suite 11, Fargo, ND 58104 USA (“Talem”), acting in its own name and on behalf of its Affiliates (listed in Appendix 3). Each a “Party” and together the “Parties”.
MATERIAL TRANSFER AND EVALUATION AGREEMENT Concluded by and between:Material Transfer and Evaluation Agreement • June 20th, 2023
Institute of Chemical Process Fundamentals of the Academy of Science of the Czech Republic, public research institution (Ústav chemických procesů AV ČR, v.v.i.)